Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 55 to 85 at the time of consent
Informant available and willing (remotely or in-person) to provide information about sleep patterns and cognitive functioning who spends >8 hours per week with primary subject
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
Study Summary
This trial uses a software to study patients' brainwaves to see if it's effective.
Who is the study for?
The SPARK Neuro REMIND Study is for individuals aged 55 to 85 with cognitive impairment or Alzheimer's, who have someone willing to report on their sleep and cognition. Participants must be able to consent and follow the study protocol. Exclusions include inability to stay still for EEG, certain medical conditions, substance use disorders, and specific medications.Check my eligibility
What is being tested?
This trial tests the SPARK Test software used alongside an FDA-cleared EEG system. It aims to collect and analyze brain activity data (EEG) from participants in order to understand cognitive impairments better.See study design
What are the potential side effects?
Since this study involves non-invasive EEG recording with no medication involved, side effects are minimal but may include discomfort from wearing the EEG cap or sitting still during the test.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 55 and 85 years old.
Select...
I have someone who can report on my sleep and thinking skills.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of patients SPARK Test data
Software malfunction occurrences
Secondary outcome measures
Mean absolute error for specific cognitive assessment
Other outcome measures
Alzheimer's Disease positive vs. negative indication for biomarker-confirmed AD
Trial Design
1Treatment groups
Experimental Treatment
Group I: TBDExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Spark Neuro Inc.Lead Sponsor
2 Previous Clinical Trials
71 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have epilepsy or a long-term seizure disorder.You have a problem with using drugs or alcohol.You have metal in your head that is not related to dental work.I am between 55 and 85 years old.You scored a certain way on a test that shows you may have trouble with your memory and thinking.I have a skin condition on my scalp that could interfere with medical equipment.I am currently taking medication that cannot be stopped, including painkillers, sleep aids, or mood stabilizers.I have someone who can report on my sleep and thinking skills.I can't stay still for 30 minutes during a brain wave test.I have had a stroke, severe head injury, or surgery on my skull.
Research Study Groups:
This trial has the following groups:- Group 1: TBD
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in this experiment still open to the public?
"Affirmative. Clinicaltrials.gov attests that recruitment for this medical trial, which was initially announced on May 18th 2022, is still ongoing. It requires 800 participants from a single locality to join the study."
Answered by AI
To what extent is participation in this experiment widespread?
"Affirmative. Data accessible via clinicaltrials.gov confirms that this medical trial, which was initially shared on May 18th 2022, is actively searching for participants. A total of 800 individuals are being recruited from 1 health centre."
Answered by AI
Is eligibility for this trial limited to those over twenty years of age?
"Patients aged 55 to 85 years old are being considered for this clinical trial."
Answered by AI
Am I qualified to join this medical experiment?
"This clinical trial is seeking 800 individuals of between 55 and 85 years old with a diagnosis of alzheimer disease. To be considered for the study, these criteria must be met."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger